CONFIRM DIAGNOSIS CUTANEOUS MELANOMA

Brand Owner Address Description
CONFIRMDX-CM Castle Biosciences Incorporated 505 S. Friendswood Drive, ste 400 Friendswood TX 77546 CONFIRM DIAGNOSIS CUTANEOUS MELANOMA;CONFIRM MEDICS CM;CONFIRM DX-CM;Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic cutaneous melanoma, namely genetic expression profiling and gene sequencing relating to dermatological cutaneous melanoma, and providing medical information; and providing information for risk of metastasis and diagnostic support thereby effecting changes in treatment plans;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.